CSF-1 is currently in Phase 2 clinical development
CSF-1 IS A CORRECTIVE EYE DROP being developed to improve the quality of life for people with presbyopia by providing an alternative to reading glasses and invasive surgical procedures.
Delivered as a topical solution directly to the eyes, CSF-1 contains a proprietary combination of existing and well-studied ingredients with the potential to restore near vision in people with presbyopia.
CSF-1 IS DESIGNED TO BE CONVENIENT AND ON DEMAND.
Clinical trial results to date have demonstrated significant improvements in near vision and a superior safety profile, supporting potential quality of life improvement in people with presbyopia.
By repurposing existing and well-studied molecules that have been researched for many years, CSF-1 is designed to be not only effective, but also safe, comfortable, convenient, and easy-to-use.